Brian Layden, MD, PhD (@brian_layden) profile picture

Endocrinologist and Division Chief at UI health, Professor of Medicine, Director of the UIC Diabetes Center

Joined April 2017
Photo by Brian Layden, MD, PhD (@brian_layden)Photo by Brian Layden, MD, PhD (@brian_layden)Photo by Brian Layden, MD, PhD (@brian_layden)
Brian Layden, MD, PhD retweeted
🎉 Introducing 3 of our 6 Diabetes Pilot Grant recipients! Meet Lauretta Quibb, PhD, RN, CDCES, FAHA, FAAN, Clinical Professor at the UIC College of Nursing. 🤖 Her pilot project explores how AI can interpret data from Hybrid Closed-Loop Automated Insulin Delivery (AID) systems to advance diabetes care. 🔬 We look forward to the impact of her innovative research! #Diabetes  #Research #Healthcare #UIC #Nursing
1
1
90
Brian Layden, MD, PhD retweeted
📢 New JMIR publication alert! Can a routine chest X-ray help predict type 2 diabetes risk? lead Author Pola Lydia Lagari and mentor Dr. Brian Layden, along with their research team, on their new JMIR publication. Their study shows how deep learning from chest X-rays may help identify patients at higher risk for type 2 diabetes in a diverse population. 👉 Read the study: ai.jmir.org/2026/1/e85248 #UICResearch #CardiovascularDisease #Type2Diabetes #DiabetesResearch
1
1
70
Brian Layden, MD, PhD retweeted
🌈 Happy Pride Month from the Division of Endocrinology, Diabetes, and Metabolism! Wishing all a happy, loved, supported, and pride-filled month. We’re celebrating the LGBTQ+ community today and every day. ❤️ Happy Pride! 🩷❤️🧡💛💚🩵💙💜 #PrideMonth #HappyPride #LoveIsLove #Chicago #UIC #LGBTQ #Inclusion
1
1
54
Brian Layden, MD, PhD retweeted
🎉 Introducing 2 of Our 6 Diabetes Pilot Grant Recipients! Meet Dr. Sirimon Reutrakul, one our incredible endocrinologists at the UI Health Diabetes Center! 💙 Dr. Reutrakul specializes in treating type 1 and type 2 diabetes and has clinical interest in glucose metabolism. As a recipient of our Diabetes Pilot Grant, she is exploring ways to improve cardiac autonomic neuropathy and hypoglycemia awareness in people with type 1 diabetes through respiratory muscle training. Fun facts: she’s an avid bird watcher, fluent in both Thai and English, and the cutest cats! 🐱 We look forward to seeing the impact of Dr. Reutrakul’s research journey. #uic #chicago #science #diabetes #research
1
2
82
Brian Layden, MD, PhD retweeted
Always rewarding to see our research gaining traction beyond our immediate field. Dr. Mohamed A. Is grateful for this endorsement emphasizing the clinical and mechanistic importance of ADMA–DDAH–NOx imbalance in long COVID. This kind of cross-disciplinary attention is critical to advancing understanding of long COVID @AbeerMMohamed17
Endothelial and cardiac dysfunction in long COVID with cardiovascular symptoms is associated with imbalance in the ADMA–DDAH–NOx pathway 🚨AND AGAIN: “Mild” COVID isn’t over when it’s over! ➡️This cross-sectional USA study (RECOVER cohort, n=49) compared never-infected controls (n=10), fully recovered COVID-19 (PASC−, n=20), and long-COVID patients with persistent cardiovascular symptoms ≥12 weeks (PASC+, n=19). ➡️The ADMA–DDAH–NOx axis is a central regulator of endothelial function: asymmetric dimethylarginine (ADMA) inhibits endothelial nitric oxide (NOx) synthase, while dimethylarginine dimethylaminohydrolase (DDAH) clears most circulating ADMA. ➡️Study findings: - PASC+ showed markedly elevated inflammation and thrombosis: hs-CRP nearly 3× higher (p=0.002) and D-dimer >3× higher (p=0.001) vs controls. - Core finding: profound imbalance in the ADMA–DDAH–NOx pathway, with ADMA ~4.8× higher (p=0.0095), NOx significantly lower (p=0.0007), and only modest DDAH upregulation (insufficient compensation). - This drove severe endothelial dysfunction: brachial FMD reduced by 51% (p=0.0002) and microvascular FMD by 33% (p=0.0015). - Cardiac involvement: lower ejection fraction, impaired global longitudinal strain, higher hs-troponin-I/NT-proBNP (all p<0.05), with strong inverse correlations linking ADMA elevation to NOx depletion and vascular/cardiac damage. ➡️Authors conclude the pathway disruption is a distinct, sustained feature of symptomatic long COVID, not seen in asymptomatic recovery. ➡️Important notes: 1. The study itself provides zero information on acute COVID-19 severity and never classifies any patients as mild/moderate/severe. It never actually measured or reported severity. 2. But the authors state in the discussion: “our PASC+ group included individuals who initially had mild illness but developed long-term symptoms, indicating that significant endothelial impairment can persist for months after infection, even in non-hospitalized patients.” That’s exactly why this is so alarming. ➡️Detecting this imbalance is straightforward via ADMA blood testing. Treatments today remain indirect and supportive, which is why urgent investment in DDAH-targeted therapies is essential. ‼️This study needs further confirmation, but it is critically important: it identifies a precise, targetable molecular driver (ADMA–DDAH–NOx imbalance) behind the endothelial and cardiac damage that continues to cripple millions with long COVID, opening the door to therapies that could prevent (lifelong) heart disease. #YouOnlyHaveOneHeart frontiersin.org/journals/car…
1
1
146
Brian Layden, MD, PhD retweeted
📢 New study just dropped Dr. Kineman is a co-author on research investigating Low-Intensity Vibration (LIV) in diabetic mice. 🐭 The findings are surprising—and reveals exactly what changed in tissue repair. Curious? Click the link below ! 👇 🔗pubmed.ncbi.nlm.nih.gov/4172… #MedicalResearch #DiabetesCare #chicago #science
1
3
91
Brian Layden, MD, PhD retweeted
🧠💫 New research spotlight The team uncovered how arsenic reshapes microglial responses—revealing a dynamic shift that offers fresh insight into how environmental exposures impact brain health. Curious what this means for brain health? 👀 🔗 Read more: pubmed.ncbi.nlm.nih.gov/4201… #Neuroscience #Toxicology #Microglia #BrainHealth #Research #chicago #science
1
2
51
Brian Layden, MD, PhD retweeted
🦠💊 New meta-analysis by @AbeerMMohamed17 in @Nutrients_MDPI: Probiotics/synbiotics after bariatric surgery may modestly improve BMI, blood sugar (HbA1c), triglycerides, liver enzymes, and vitamin D levels. 📊 Benefits are stronger with mini-gastric bypass & perioperative use. 📖 Read: mdpi.com/2072-6643/17/13/219… #BariatricSurgery #GutHealth #Probiotics #Metabolism #ObesityResearch
1
1
245
Brian Layden, MD, PhD retweeted
Lipidomic profiling of human adiposomes identifies specific lipid shifts linked to obesity and cardiometabolic risk insight.jci.org/articles/vie…
3
6
334
Take a ride for a cause! 🚴‍♀️Join us for the Sweet Ride Event to support our mission of transforming diabetes care and research in Chicago. Saturday, October 4, 2025 🕒  9 AM – 12 PM 📍 Willow Springs, IL Register today at qrco.de/bfDt5u @Diabetes_UIC
3
4
344
Brian Layden, MD, PhD retweeted
Congratulations to Dr. Mohamed @AbeerMMohamed17 and the team on their new publication, “Lipidomic profiling of human adiposomes reveals specific lipid shifts linked to obesity and cardiometabolic risk.” Insightful work that advances our understanding of metabolic health! 🎉🧬 #Lipidomics #Metabolism #ObesityResearch
Excited to share our latest work in JCI Insight: Lipidomic profiling of human adiposomes reveals specific lipid shifts linked to obesity and cardiometabolic risk. Proud of the amazing team behind this! @Diabetes_UIC @brian_layden @uiccom @UICDom @UICAHS
1
3
156
Brian Layden, MD, PhD retweeted
We are being represented by our faculty @AbeerMMohamed17 at the #ADA2025! Her poster on obesity-associated adiposomes and their role in vascular smooth muscle cell hypercontractility sparked great discussions. Proud of the team’s insights into metabolic–vascular crosstalk! 💪🧪 #Adiposomes #VascularBiology #MetabolismResearch
Proud moment at #ADA2025! Our poster on obesity-associated adiposomes and vascular smooth muscle cell hypercontractility. @Diabetes_UIC @uiccom @UICDom @UICAHS @ADA_DiabetesPro
1
4
175
Our PhD candidate @IzabelaHawro will show her work-in-progress next Wednesday @uiccom #COMRB2175
3
16
462
Brian Layden, MD, PhD retweeted
Our talented postdoc, Kai Xu @aprilchris123 won the best poster award at the 19th Diabetes Day @KovlerDiabetes @xulab_uic @UICPhysiology @uiccom
2
6
366
Brian Layden, MD, PhD retweeted
Hi!!Please take a break from surfing the Internet for a moment—do you know what exciting event happened in May? The Xu Lab at UIC's College of Medicine celebrated the graduation of three PhD students at once! Huge congratulations to all of them!@Diabetes_UIC @thisisUIC @UIHealth
1
4
9
389
Congrats @Diabetes_UIC
🎓 Huge congratulations to @vtorre26 for successfully defending her PhD thesis! Her work explored estrogen signaling in the vlVMH and its role in regulating adipose tissue function. We’re so proud of Dr. Torres and can’t wait to see what she does next!
1
3
182
Brian Layden, MD, PhD retweeted
📢📅Monday May 5th - Chioma Nnyamah @Chioma_PhDToBe will have her PhD Thesis Defense - on Moss Auditorium COMRB 1020 at 2,30 pm. @gemssa_uic @UICPhysiology @uiccom Thesis Title: "The Role of Adipose-Specific Free Fatty Acid Receptor 2 in Obesity and Associated Metabolic Dysfunction" Advisor: Brian Layden, PhD. @brian_layden @UICDom
2
5
155